SI-BONE, Inc.
Clinical trials sponsored by SI-BONE, Inc., explained in plain language.
Medical device company specializing in minimally invasive sacroiliac joint fusion.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New implant aims to fuse painful pelvic joint
Disease control OngoingThis study tests a device called iFuse TORQ, which is surgically implanted to fuse the sacroiliac joint—a common source of lower back and buttock pain. The trial includes 110 adults who have had pain for at least 6 months and haven't found relief from non-surgical treatments. Res…
Phase 4 • Sponsor: SI-BONE, Inc. • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
1,000 patients to report on SI joint implant outcomes in new study
Disease control OngoingThis study follows 1,000 adults who receive an SI-BONE implant for sacroiliac joint pain. Participants fill out online questionnaires about their pain and satisfaction over time. The goal is to see how well the implant works in everyday medical practice.
Sponsor: SI-BONE, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New implant aims to improve spinal fusion outcomes in pelvic surgery
Disease control OngoingThis study is testing a device called iFuse Bedrock Granite in 200 adults having spinal fusion surgery that also involves fixing the pelvis. The goal is to see if the implant is safe, works well, and helps reduce pain and improve quality of life. Participants will be followed for…
Sponsor: SI-BONE, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC